Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine combinations for chemotherapy-induced neuropathy
NCT06091553Phase 2Recruiting
- Sponsor
- Beni Suef University
- Start
- Oct 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine, gabapentin, amitriptyline in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Beni Suef University. Started Oct 2023; status: recruiting.
02
Drugs
duloxetinegabapentinamitriptyline
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT06091553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06091553.